Latest Sensorium Therapeutics News & Updates

See the latest news and media coverage for Sensorium. We track all announcements, press releases, and industry mentions in real time, all in one place.

Sensorium Therapeutics (Sensorium)

Clinical-stage biotech discovering CNS therapies from natural compounds

sensorium.bio

Headquarters: Boston, United States
Founded year: 2021
Company type: Private company
Number of employees: 25–50

Last updated Today

Latest news about Sensorium Therapeutics (Sensorium)

In short: Sensorium advanced its lead anxiety drug candidate SNTX-2643 and appointed Cole Brown, M.D., as Chief Medical Officer.

Company announcements

June 2 Sensorium

Sensorium's CMO presented at ASCP meeting

He reported feeling energized by advances in new agents, DSM evolution, and AI integration.

May 28 Sensorium

Sensorium discusses mental health report findings

The report shows 1.17 billion people have a mental health disorder, making it the leading cause of disability.

May 27 Sensorium

Sensorium presents SNTX-2643 data at ASCP, appoints CMO

The presentation includes Phase 1a study design and preclinical data; a Clinical Advisory Board is formed with leading experts.

8 July 2025 Sensorium

Sensorium receives FDA IND clearance for SNTX-2643

The first-in-class anxiolytic is a precision serotonin modulator, with first-in-human dosing in Q3 2025.

Media coverage

May 27 Morningstar

Sensorium Therapeutics to Present SNTX-2643 Mechanistic Data and Phase 1a Study Design at ASCP 2026

Company also announces appointment of Cole Brown, M.D., as Chief Medical Officer and formation of a Clinical Advisory Board CAMBRIDGE, Mass., May 27, 2026 /PRNewswire...

29 August 2025 Finsmes

Sensorium Therapeutics Raises $25M in Series A Funding

Sensorium Therapeutics, a Boston, MA-based neuroscience therapeutics company, raised $25m in Series A funding...

8 July 2025 Yahoo Finance

Sensorium Therapeutics Receives FDA IND Clearance for SNTX-2643, a First-in-Class, Rapid-Acting Anxiolytic

BOSTON, July 8, 2025 /PRNewswire/ -- Sensorium Therapeutics, Inc. (Sensorium), a neuroscience therapeutics company inspired by nature and guided by human biology to transform mental...

22 June 2024 KTLA

Sensorium Therapeutics Highlights Promising Data on Lead Assets Targeting Anxiety & Epilepsy at Neuroscience 2024

Preclinical data reveal ongoing progress of lead assets and discovery platform as the company prepares to enter the clinic in early 2025 BOSTON, Oct. 10...

Never miss news about Sensorium

Track Sensorium and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Sensorium competitors & trending companies

Browse news for competitors to Sensorium and other trending companies.